Literature DB >> 11158823

Nonpenetrating glaucoma surgery.

P A Netland.   

Abstract

OBJECTIVE: The purpose of this document is to describe nonpenetrating glaucoma surgery and to examine the available evidence to assess the efficacy and complications following the procedures.
METHODS: A literature search that was conducted in February 2000 and repeated in September 2000 for the years 1968 to 2000 retrieved over 100 citations that matched the search criteria. Thirty three articles were selected as relevant to the assessment, and they were each evaluated by the panel methodologist for the quality of the evidence presented.
RESULTS: One randomized controlled trial comparing nonpenetrating deep sclerectomy to trabeculectomy has been reported. The majority of the published literature contains information from case series, which are not randomized and lack a control group. The two major variations of nonpenetrating glaucoma surgery described in the literature are nonpenetrating deep sclerectomy and viscocanalostomy. The procedures are not familiar to many ophthalmologists, and reports often describe a difficult learning period. These procedures appear to lower intraocular pressure, usually to the mid to high teens, although follow-up is limited in most published reports. Postoperative complications due to overfiltration and hypotony are uncommon in the literature. There is no strong evidence indicating the mechanism of action, reports on bleb formation are lacking, and clinical correlation and gonioscopic findings have been minimal.
CONCLUSIONS: Nonpenetrating glaucoma surgery has the potential to reduce intraocular pressure while minimizing the risk of postoperative relative hypotony and the complications associated with hypotony. Randomized clinical trials are needed to assess these procedures and to determine their role in the clinical management of glaucoma patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158823     DOI: 10.1016/s0161-6420(00)00647-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  What comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities.

Authors:  Tianjing Li; S Swaroop Vedula; Roberta Scherer; Kay Dickersin
Journal:  Ann Intern Med       Date:  2012-03-06       Impact factor: 25.391

Review 2.  Acupuncture for glaucoma.

Authors:  Simon K Law; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

3.  CANALOPLASTY AFTER LASER TRABECULOPLASTY.

Authors:  Gabriela Denisa Caileanu
Journal:  Rom J Ophthalmol       Date:  2015 Jan-Mar

4.  Results of a modified non-penetrating deep sclerectomy in the treatment of open angle glaucoma with or without cataract.

Authors:  George Kitsos; Miltiades Aspiotis; Yannis Alamanos; Konstantinos Psilas
Journal:  Clin Ophthalmol       Date:  2010-07-30

Review 5.  Acupuncture for glaucoma.

Authors:  S K Law; T Li
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 6.  Management of complications in glaucoma surgery.

Authors:  Lingam Vijaya; Panday Manish; George Ronnie; B Shantha
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

7.  Acupuncture for glaucoma.

Authors:  Simon K Law; Lin Wang; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2020-02-07

8.  Safety and efficacy of canaloplasty versus trabeculectomy in treatment of glaucoma.

Authors:  Haifeng Liu; Haitao Zhang; Yanhua Li; Han Yu
Journal:  Oncotarget       Date:  2017-07-04

9.  European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.

Authors: 
Journal:  Br J Ophthalmol       Date:  2017-06       Impact factor: 4.638

10.  The Effects of Trabeculectomy on Ocular Pulse Amplitude in Patients with Glaucoma.

Authors:  Yalcin Karakucuk
Journal:  Beyoglu Eye J       Date:  2019-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.